References

Manfredi M, Polonelli L, Aguirre-Urizar JM, Carozzo M, McCullough MJ. Urban legends series: oral candidosis. Oral Dis. 2013; 19:245-261
Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from patients in various parts of the world: a systematic review. Int J Infect Dis. 2010; 14:e945-e966
Williams D, Lewis M. Pathogenesis and treatment of oral candidosis. J Oral Microbiol. 2011; 28
Sitheeque M, Samararanayake LP. Chronic hyperplastic candidosis/candidiasis (candida leucoplakia). Crit Rev Oral Biol Med. 2003; 14:253-267
Samaranayake LP, Cheung LK. Samaranayake YH. Candidiasis and other fungal diseases of the mouth. Dermatol Ther. 2002; 15:251-269
Scully C, Eikabir M, Samaranayake LP. Candida and oral candidosis; a review. Crit Rev Oral Biol Med. 1994; 5:125-157
MacFarlane TW, McGill JC, Samaranayake LP. Antibiotic sensitivity and phage typing of Staphyloccocus aureus isolated from non-hospitalized patients with angular cheilitis. J Hospital Infection. 1984; 5:444-446
Farah CS, Ashman RB, Challacombe SJ. Oral candidosis. Clin Dermatol. 2000; 18:553-562
Thomas MS, Parolia A, Kundabala M, Vikram M. Asthma and oral health: a review. Aus Dent J. 2010; 55:128-133
Sahay JN, Chatterjee SS, Stanbridge TN. Inhaled corticosteroid aerosols and candidiasis. Br J Dis Chest. 1979; 73:164-168
Shaw NJ, Edmunds AT. Inhaled beclomethasone and oral candidiasis. Arch Dis Child. 1986; 61:788-790
Ellepola ANB, Samaranayake LP. Inhalational and topical steroids, and oral candidosis: a mini review. Oral Dis. 2001; 7:211-216
Knight L, Fletcher J. Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids and diabetes mellitus. J Inf Dis. 1971; 123:371-377
Hibino K, Wong R, Hagg U, Samaranayake LP. The effects of orthodontic appliances on Candida in the human mouth. Int J Paed Dent. 2009; 19:301-308
Bessa CN, Santos PB, Aguiar MF, V do Carma MA. Prevalence of oral mucosal alterations in children from 0 to 12 years old. J Oral Pathol Med. 2004; 33:17-22
Darwazeh AG, Al-Bashir A. Oral candida flora in healthy infants. J Oral Pathol Med. 1995; 24:361-364
Sitheeque MM, Samaranayake LP. Chronic hyperplastic candidosis/candidiasis (candidal leukoplakia). Crit Rev Oral Biol Med. 2003; 14:253-267
Sag C, Ozden FO, Acikgoz G, Anlar FY. The effects of combination treatment with a long-acting beta2-agonist and a corticosteroid on salivary flow rate, secretory immunoglobulin A and oral health in children and adolescents with moderate asthma: a 1-month, single blind clinical study. Clin Ther. 2007; 29:2236-2242
Epstein JB. Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clinic. 2012; 62:400-422
Leggot P. Oral complications in the pediatric population. NCI Monographs. 1990; 9:129-131
Iro H, Zenk J. Salivary gland diseases in children. Curr Topics Otolaryngol Head Neck Surg. 2014; 13:1-30
Soysa NS, Samaranayake LP, Ellepola AB. Diabetes mellitus as a contributory factor in oral candidosis. Diabet Med. 2005; 23:455-459
Kadir T, Pisiriciler R, Akyuz S, Yarat A, Emekli N, Ipbuker A. Mycological and cytological examination of oral candida carriage in diabetic patients and non-diabetic control subjects: thorough analysis of local aetiologic and systemic factors. J Oral Rehab. 2002; 29:452-457
Rozeli M, Esther G, Claudete R. Oral manifestations of diabetes mellitus in controlled and uncontrolled patients. Braz Dent J. 1995; 6:131-136
Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988; 318:1315-1321
Samaranayake LP. Nutritional factors and oral candidosis. J Oral Pathol. 1986; 15:61-65
Soysa NS, Samaranayake LP, Ellepola AB. Antimicrobials as a contributory factor in oral candidosis – a brief overview. 2008; 14:138-143
Nguyen R, Su J. Treatment of acne vulgaris. J Paediatr Child Health. 2011; 21:119-125
Tredwin CJ, Scully C, Bagan-Sebastian JV. Drug-induced disorders of teeth. J Dent Res. 2005; 84:596-602
Cortes-Ramirez J, Cortes Ayala C Oral alterations in children with cancer. Literature review. J Oral Res. 2014; 3:262-268
Belfield PM, Dwyer AA. Oral complications of childhood cancer and its treatment: current best practice. Eur J Cancer. 2004; 40:1035-1041
Ramos-Gomez FJ, Flaitz C, Catapano P, Murray P, Milnes AR, Dorenbaum A. Classification, diagnostic criteria, and treatment recommendations for orofacial manifestations in HIV-infected pediatric patients. Collaborative Workgroup on Oral Manifestations of Pediatric HIV Infection. J Clin Pediatr Dent. 1999; 23:85-96
Pinheiro R, Franca T, Ribeiro C, Leao J, De Souza I, Castro G. Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era. J Oral Pathol Med. 2009; 38:613-622
Niimi M, Firth N, Cannon R. Antifungal drug resistance of oral fungi. Odontology. 2010; 98:15-25

Oral candidosis in the paediatric patient

From Volume 44, Issue 2, February 2017 | Pages 132-138

Authors

Kevin Ryan

BDS, MB, BCh, BAO

StR in Oral Medicine, UK

Articles by Kevin Ryan

Mona Agel

BDS, MJDF RCS(Eng), MDPH

Locum StR in Paediatric Dentistry, UK

Articles by Mona Agel

Halla Zaitoun

BDS, MFDS, MDentSci, FRCS(Paed)

Senior House Officer, University Dental Hospital of Manchester, Higher Cambridge Street, Manchester M15 6FH.

Articles by Halla Zaitoun

Anne M Hegarty

BDentSc, MSc(OM), MBBS, MFD, RCSI, FDS(OM) RCS

Consultant and Honorary Clinical Lecturer in Oral Medicine, Charles Clifford Dental Hospital, Sheffield S10 2ZS

Articles by Anne M Hegarty

Abstract

Oral candidosis can present in childhood with recognizable mucosal changes. It may be associated with predisposing factors or suggest underlying systemic disease such as poorly controlled diabetes or an immunosuppressed state. Investigations are often required and management includes addressing predisposing factors in addition to prescribing topical or systemic antifungal therapy.

CPD/Clinical Relevance: It is important for general dental practitioners to recognize oral mucosal changes related to candidal infection and refer to secondary care for further assessment when appropriate.

Article

Candida albicans is the most common candida species isolated from the oral cavity in both healthy and diseased states.1 However, there has been an increase in the incidence of non-albicans species such as C. glabrata, C. tropicalis and C. krusei in recent years.2

It is important to differentiate between candida as a commensal and candida infection (candidosis). Commensal oral carriage of candida can occur in up to 80% of healthy individuals.3 Progression from harmless commensal to pathogenic organism is often due to predisposing host factors which often relate to a weakening of host immune defences.3 In the paediatric setting it is important to consider these predisposing factors as oral candidosis may reflect an undiagnosed systemic condition.

Factors that predispose to oral candidosis relate primarily to the host. The virulence factors unique to Candida albicans which allow it to colonize the oral mucosal surface so effectively are listed in Table 1.

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available